<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas13719-bib-0014">
 <label>14</label>
 <mixed-citation publication-type="journal" id="cas13719-cit-0014">
  <string-name>
   <surname>Oki</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Ogura</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Kato</surname>
   <given-names>H</given-names>
  </string-name>, et al. 
  <article-title>Phase II study of a salvage regimen using cyclophosphamide, high‐dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B‐cell non‐Hodgkin's lymphoma</article-title>. 
  <source xml:lang="en">Cancer Sci</source>. 
  <year>2008</year>;
  <volume>99</volume>:
  <fpage>179</fpage>‐
  <lpage>184</lpage>.
  <pub-id pub-id-type="pmid">17991293</pub-id>
 </mixed-citation>
</ref>
